1. A Narrative Review on the Management of Severe COVID-19 Infection Using Stem Cell-based therapies with a Focus on the Registered Clinical Trials
   Negin Mahmoudi et al, 2024, Qeios CrossRef
2. Developmental endothelial locus‐1 (Del‐1) antagonizes Interleukin‐17‐mediated allergic asthma
   Shu Yan et al, 2018, Immunology & Cell Biology CrossRef
3. Prospects and progress in cell therapy for acute respiratory distress syndrome
   Fernanda F. Cruz et al, 2016, Expert Opinion on Biological Therapy CrossRef
4. DEL-1-Regulated Immune Plasticity and Inflammatory Disorders
   George Hajishengallis et al, 2019, Trends in Molecular Medicine CrossRef
5. Expression of DEL-1 in alveolar epithelial cells prevents lipopolysaccharide-induced inflammation, oxidative stress, and eosinophil recruitment in acute lung injury
   Ruirui Li et al, 2022, International Immunopharmacology CrossRef
6. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
   Hua Qin et al, 2020, Protein & Cell CrossRef
7. Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases
   Miquéias Lopes-Pacheco et al, 2023, Frontiers in Pharmacology CrossRef
8. Review of the potential of mesenchymal stem cells for the treatment of infectious diseases
   Amit Sharma et al, 2021, World Journal of Stem Cells CrossRef
9. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools
   Akbar Hasanzadeh et al, 2023, ACS Pharmacology & Translational Science CrossRef
10. Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
    Jibin Han et al, 2019, Stem Cells International CrossRef
11. Downregulation of Paralemmin-3 Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Rats by Regulating Inflammatory Response and Inhibiting Formation of TLR4/MyD88 and TLR4/TRIF Complexes
    Xuxin Chen et al, 2017, Inflammation CrossRef
12. Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression
    J. Lacy Kamm et al, 2019, PLOS ONE CrossRef
13. Cellular Immunotherapy for Septic Shock. A Phase I Clinical Trial
    Lauralyn A. McIntyre et al, 2018, American Journal of Respiratory and Critical Care Medicine CrossRef
14. Advances in Stem Cell and Cell-Based Gene Therapy Approaches for Experimental Acute Lung Injury: A Review of Preclinical Studies
    Shirley H.J. Mei et al, 2016, Human Gene Therapy CrossRef
15. Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases
    Sirous Sadeghian Chaleshtori et al, 2020, Respiratory Research CrossRef
16. DEL‐1, as an anti‐neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma
    Man Jia et al, 2024, Allergy CrossRef
17. A Narrative Review on the Management of Severe COVID-19 Infection Using Stem Cell-based therapies with a Focus on the Registered Clinical Trials
    Negin Mahmoudi et al, 2024, Qeios CrossRef
18. Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases
    Luisa H. A. Silva et al, 2018, Stem Cell Research & Therapy CrossRef
19. Mesenchymal stem cells: A double‐edged sword in radiation‐induced lung injury
    Yi Yao et al, 2018, Thoracic Cancer CrossRef